Skip to main content
Erschienen in: Techniques in Coloproctology 1/2020

11.12.2019 | CONSENSUS STATEMENT

Measuring pelvic floor disorder symptoms using patient-reported instruments: proceedings of the consensus meeting of the pelvic floor consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction

verfasst von: L. G. Bordeianou, J. Anger, M. Boutros, E. Birnbaum, J. C. Carmichael, K. Connell, E. J. B. De, A. Mellgren, K. Staller, S. A. Vogler, M. M. Weinstein, F. A. Yafi, T. Hull, Members of the Pelvic Floor Disorders Consortium Working Groups on Patient-Reported Outcomes

Erschienen in: Techniques in Coloproctology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

The patient-reported outcome (PRO) is defined as a report of the status of a patient’s health condition that comes directly from the patient, without the interpretation of the patient’s response by a clinician or anyone else [1]. Beginning with the introduction of the Karnofsky performance status scale in 194 [2, 8] health-related quality of life (HRQoL) has become an increasingly important metric in the field of health care research. The growing prominence of HRQoL signifies a shift in focus from clinical outcomes related solely to survival and complications, to outcomes that include the patient’s perspective. Studies have shown that clinicians’ assessments of outcomes that matter often differ significantly from outcomes reported by patients. A considerable disconnect can occur between what the observer deems important versus what the patient considers important in terms of symptom management and the balance between relief and quality of life [3, 4]. …
Literatur
1.
Zurück zum Zitat McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD (2011) Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res 11:163–169PubMedPubMedCentral McLeod LD, Coon CD, Martin SA, Fehnel SE, Hays RD (2011) Interpreting patient-reported outcome results: US FDA guidance and emerging methods. Expert Rev Pharmacoecon Outcomes Res 11:163–169PubMedPubMedCentral
2.
Zurück zum Zitat Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer. 1:634–656 Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer. 1:634–656
3.
Zurück zum Zitat Fayers P, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes, 2nd edn. Wiley, Chichester Fayers P, Machin D (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes, 2nd edn. Wiley, Chichester
4.
Zurück zum Zitat Rockwood TH, Church JM, Fleshman JW et al (1999) Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum 42:1525–1532PubMed Rockwood TH, Church JM, Fleshman JW et al (1999) Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index. Dis Colon Rectum 42:1525–1532PubMed
5.
Zurück zum Zitat U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79 U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79
6.
Zurück zum Zitat Kyte DG, Calvert M, van der Wees PJ, ten Hove R, Tolan S, Hill JC (2015) An introduction to patient-reported outcome measures (PROMs) in physiotherapy. Physiotherapy 101:119–125PubMed Kyte DG, Calvert M, van der Wees PJ, ten Hove R, Tolan S, Hill JC (2015) An introduction to patient-reported outcome measures (PROMs) in physiotherapy. Physiotherapy 101:119–125PubMed
7.
Zurück zum Zitat Keane C, Wells C, O’Grady G, Bissett IP (2017) Defining low anterior resection syndrome: a systematic review of the literature. Colorectal Dis 19:713–722PubMed Keane C, Wells C, O’Grady G, Bissett IP (2017) Defining low anterior resection syndrome: a systematic review of the literature. Colorectal Dis 19:713–722PubMed
8.
Zurück zum Zitat Norton NJ (2004) The perspective of the patient. Gastroenterology 126(1 suppl 1):S175–S179PubMed Norton NJ (2004) The perspective of the patient. Gastroenterology 126(1 suppl 1):S175–S179PubMed
9.
Zurück zum Zitat Rockwood TH, Church JM, Fleshman JW et al (2000) Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 43:9–16PubMed Rockwood TH, Church JM, Fleshman JW et al (2000) Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum 43:9–16PubMed
10.
Zurück zum Zitat Bharucha AE, Locke GR 3rd, Seide BM, Zinsmeister AR (2004) A new questionnaire for constipation and faecal incontinence. Aliment Pharmacol Ther 20:355–364PubMed Bharucha AE, Locke GR 3rd, Seide BM, Zinsmeister AR (2004) A new questionnaire for constipation and faecal incontinence. Aliment Pharmacol Ther 20:355–364PubMed
11.
Zurück zum Zitat Bharucha AE, Zinsmeister AR, Locke GR et al (2005) Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology 129:42–49PubMed Bharucha AE, Zinsmeister AR, Locke GR et al (2005) Prevalence and burden of fecal incontinence: a population-based study in women. Gastroenterology 129:42–49PubMed
12.
Zurück zum Zitat Bharucha AE, Zinsmeister AR, Locke GR, Schleck C, McKeon K, Melton LJ (2006) Symptoms and quality of life in community women with fecal incontinence. Clin Gastroenterol Hepatol 4:1004–1009PubMed Bharucha AE, Zinsmeister AR, Locke GR, Schleck C, McKeon K, Melton LJ (2006) Symptoms and quality of life in community women with fecal incontinence. Clin Gastroenterol Hepatol 4:1004–1009PubMed
13.
Zurück zum Zitat Bharucha AE, Fletcher JG, Camilleri M, Edge J, Carlson P, Zinsmeister AR (2014) Effects of clonidine in women with fecal incontinence. Clin Gastroenterol Hepatol. 12:843–851 (quiz e44) PubMed Bharucha AE, Fletcher JG, Camilleri M, Edge J, Carlson P, Zinsmeister AR (2014) Effects of clonidine in women with fecal incontinence. Clin Gastroenterol Hepatol. 12:843–851 (quiz e44) PubMed
14.
Zurück zum Zitat Bharucha AE, Dunivan G, Goode PS et al (2015) Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop. Am J Gastroenterol 110:127–136PubMed Bharucha AE, Dunivan G, Goode PS et al (2015) Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop. Am J Gastroenterol 110:127–136PubMed
15.
Zurück zum Zitat Jorge JM, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36:77–97PubMed Jorge JM, Wexner SD (1993) Etiology and management of fecal incontinence. Dis Colon Rectum 36:77–97PubMed
16.
Zurück zum Zitat Vaizey CJ, Carapeti E, Cahill JA, Kamm MA (1999) Prospective comparison of faecal incontinence grading systems. Gut 44:77–80PubMedPubMedCentral Vaizey CJ, Carapeti E, Cahill JA, Kamm MA (1999) Prospective comparison of faecal incontinence grading systems. Gut 44:77–80PubMedPubMedCentral
17.
Zurück zum Zitat Hussain ZI, Lim M, Stojkovic S (2014) The test-retest reliability of fecal incontinence severity and quality-of-life assessment tools. Dis Colon Rectum 57:638–644PubMed Hussain ZI, Lim M, Stojkovic S (2014) The test-retest reliability of fecal incontinence severity and quality-of-life assessment tools. Dis Colon Rectum 57:638–644PubMed
18.
Zurück zum Zitat Brown HW, Wexner SD, Lukacz ES (2013) Factors associated with care seeking among women with accidental bowel leakage. Female Pelvic Med Reconstr Surg 19:66–71PubMed Brown HW, Wexner SD, Lukacz ES (2013) Factors associated with care seeking among women with accidental bowel leakage. Female Pelvic Med Reconstr Surg 19:66–71PubMed
19.
Zurück zum Zitat Rothbarth J, Bemelman WA, Meijerink WJ et al (2001) What is the impact of fecal incontinence on quality of life? Dis Colon Rectum 44:67–71PubMed Rothbarth J, Bemelman WA, Meijerink WJ et al (2001) What is the impact of fecal incontinence on quality of life? Dis Colon Rectum 44:67–71PubMed
20.
Zurück zum Zitat Bharucha AE, Seide BM, Zinsmeister AR, Melton LJ 3rd (2008) Relation of bowel habits to fecal incontinence in women. Am J Gastroenterol 103:1470–1475PubMedPubMedCentral Bharucha AE, Seide BM, Zinsmeister AR, Melton LJ 3rd (2008) Relation of bowel habits to fecal incontinence in women. Am J Gastroenterol 103:1470–1475PubMedPubMedCentral
21.
Zurück zum Zitat Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr (1999) Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 34:870–877PubMed Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr (1999) Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol 34:870–877PubMed
22.
Zurück zum Zitat Spiegel BM, Hays RD, Bolus R et al (2014) Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol 109:1804–1814PubMedPubMedCentral Spiegel BM, Hays RD, Bolus R et al (2014) Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol 109:1804–1814PubMedPubMedCentral
23.
Zurück zum Zitat Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O (2005) Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol 40:540–551PubMed Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O (2005) Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol 40:540–551PubMed
24.
Zurück zum Zitat Heaton KW, O’Donnell LJ (1994) An office guide to whole-gut transit time. Patients’ recollection of their stool form. J Clin Gastroenterol. 19:28–30PubMed Heaton KW, O’Donnell LJ (1994) An office guide to whole-gut transit time. Patients’ recollection of their stool form. J Clin Gastroenterol. 19:28–30PubMed
25.
Zurück zum Zitat Cameron AP, Smith AR, Lai HH, LURN Study Group et al (2018) Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence. Neurourol Urodyn 37:2586–2596PubMedPubMedCentral Cameron AP, Smith AR, Lai HH, LURN Study Group et al (2018) Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence. Neurourol Urodyn 37:2586–2596PubMedPubMedCentral
26.
Zurück zum Zitat Khanna D, Hays RD, Shreiner AB et al (2017) Responsiveness to change and minimally important differences of the patient-reported outcomes measurement information system gastrointestinal symptoms scales. Dig Dis Sci 62:1186–1192PubMedPubMedCentral Khanna D, Hays RD, Shreiner AB et al (2017) Responsiveness to change and minimally important differences of the patient-reported outcomes measurement information system gastrointestinal symptoms scales. Dig Dis Sci 62:1186–1192PubMedPubMedCentral
27.
Zurück zum Zitat Varma MG, Wang JY, Berian JR, Patterson TR, McCrea GL, Hart SL (2008) The constipation severity instrument: a validated measure. Dis Colon Rectum 51:162–172PubMed Varma MG, Wang JY, Berian JR, Patterson TR, McCrea GL, Hart SL (2008) The constipation severity instrument: a validated measure. Dis Colon Rectum 51:162–172PubMed
29.
Zurück zum Zitat Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322–330PubMed Avery K, Donovan J, Peters TJ, Shaw C, Gotoh M, Abrams P (2004) ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn 23:322–330PubMed
30.
Zurück zum Zitat Lemack GE, Zimmern PE (1999) Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire. Urology 54:461–466PubMed Lemack GE, Zimmern PE (1999) Predictability of urodynamic findings based on the Urogenital Distress Inventory-6 questionnaire. Urology 54:461–466PubMed
31.
Zurück zum Zitat Donovan JL, Peters TJ, Abrams P, Brookes ST, de Rosette JJ, Schäfer W (2000) Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol. 164:1948–1955PubMed Donovan JL, Peters TJ, Abrams P, Brookes ST, de Rosette JJ, Schäfer W (2000) Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol. 164:1948–1955PubMed
32.
Zurück zum Zitat Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P (2004) A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol 191:73–82PubMed Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P (2004) A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol 191:73–82PubMed
33.
Zurück zum Zitat Barry MJ, Fowler FJ Jr, O’Leary MP et al (1992) The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148:1549–1564PubMed Barry MJ, Fowler FJ Jr, O’Leary MP et al (1992) The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148:1549–1564PubMed
34.
Zurück zum Zitat Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P (1996) The bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol 77:805–812PubMed Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P (1996) The bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol 77:805–812PubMed
35.
Zurück zum Zitat Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA (1995) Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 14:131–139PubMed Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl JA (1995) Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn 14:131–139PubMed
36.
Zurück zum Zitat Choi EPH, Lam CLK, Chin W-Y (2014) Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes 12:1PubMedPubMedCentral Choi EPH, Lam CLK, Chin W-Y (2014) Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes 12:1PubMedPubMedCentral
37.
Zurück zum Zitat Bordeianou L, Hicks CW, Olariu A et al (2015) Effect of coexisting pelvic floor disorders on fecal incontinence quality of life scores: a prospective, survey-based study. Dis Colon Rectum 58:1091–1097PubMed Bordeianou L, Hicks CW, Olariu A et al (2015) Effect of coexisting pelvic floor disorders on fecal incontinence quality of life scores: a prospective, survey-based study. Dis Colon Rectum 58:1091–1097PubMed
38.
Zurück zum Zitat Barber MD, Kuchibhatla MN, Pieper CF, Bump RC (2001) Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 185:1388–1395PubMed Barber MD, Kuchibhatla MN, Pieper CF, Bump RC (2001) Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 185:1388–1395PubMed
39.
Zurück zum Zitat Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA, Continence Program in Women (CPW) Research Group (1994) Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Qual Life Res 3:291–306PubMed Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA, Continence Program in Women (CPW) Research Group (1994) Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Qual Life Res 3:291–306PubMed
40.
Zurück zum Zitat Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193:103–113PubMed Barber MD, Walters MD, Bump RC (2005) Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 193:103–113PubMed
41.
Zurück zum Zitat Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–830PubMed Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49:822–830PubMed
42.
Zurück zum Zitat Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326PubMed Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326PubMed
43.
Zurück zum Zitat Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG (2000) Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899–905PubMed Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG (2000) Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899–905PubMed
44.
Zurück zum Zitat Unger JM, Vaidya R, Gore JL (2019) Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials. Urol Oncol 37(324–330):8 Unger JM, Vaidya R, Gore JL (2019) Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials. Urol Oncol 37(324–330):8
45.
Zurück zum Zitat Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH (1999) Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 54:346–351PubMed Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH (1999) Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 54:346–351PubMed
46.
Zurück zum Zitat Rosen R, Brown C, Heiman J et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208PubMed Rosen R, Brown C, Heiman J et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208PubMed
Metadaten
Titel
Measuring pelvic floor disorder symptoms using patient-reported instruments: proceedings of the consensus meeting of the pelvic floor consortium of the American Society of Colon and Rectal Surgeons, the International Continence Society, the American Urogynecologic Society, and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction
verfasst von
L. G. Bordeianou
J. Anger
M. Boutros
E. Birnbaum
J. C. Carmichael
K. Connell
E. J. B. De
A. Mellgren
K. Staller
S. A. Vogler
M. M. Weinstein
F. A. Yafi
T. Hull
Members of the Pelvic Floor Disorders Consortium Working Groups on Patient-Reported Outcomes
Publikationsdatum
11.12.2019
Verlag
Springer International Publishing
Erschienen in
Techniques in Coloproctology / Ausgabe 1/2020
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-019-02125-4

Weitere Artikel der Ausgabe 1/2020

Techniques in Coloproctology 1/2020 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.